Open Access
Article
Type II transmembrane serine protease (TTSP) deregulation in cancer
Siobhan L Webb1,Andrew J Sanders1,Malcolm D Mason1,Wen G Jiang1
1
Metastasis and Angiogenesis Research Group, Department of Surgery, Cardiff University School of Medicine, Cardiff, UK, CF14 4XN. webbsl1@cf.ac.uk
DOI: 10.2741/3704 Volume 16 Issue 2, pp.539-552
Published: 01 January 2011
(This article belongs to the Special Issue Bone metastasis, the molecular, cellular and clinical prospects)
Abstract

The Type II transmembrane serine proteases (TTSP) are a relatively newly identified family of proteolytic enzymes that have become the subject of intense scrutiny in the field of cancer research. Advances in genome screening technology have enabled the identification of putative members and the further characterization of existing members. The TTSPs are involved in a diverse range of physiological functions and new roles continue to be discovered. A large majority of these proteases appear to play crucial roles in the development of disease, especially cancer development and progression. This review presents the current knowledge of the biological role of those TTSPs that have been identified in the development and progression of human cancers.

Share and Cite
Siobhan L Webb, Andrew J Sanders, Malcolm D Mason, Wen G Jiang. Type II transmembrane serine protease (TTSP) deregulation in cancer. Frontiers in Bioscience-Landmark. 2011. 16(2); 539-552.